CEO and Fund Manager, Renaissance Venture Capital Fund
Founding Director, Massachusetts Technology Transfer Center
Partner, Third Rock Ventures
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
What role will technology transfer play in the commercialization of the next generation of life sciences products? Biocom has asked Genetic Engineering News Editor-in-Chief John Sterling to moderate as leading experts discuss common barriers to commercialization in the life sciences industry, determine how we can overcome those barriers and what impact technology transfer will have on the future of the life sciences industry. Registration begins at 7 a.m., or register online here.